"También conocido como el 'Hospital del Conocimiento', el Hospital Universitario Dexeus es un centro de referencia en muchas de sus especialidades, siendo uno de los primeros centros privados universitarios de toda España. El Hospital Universitari Dexeus de Barcelona ofrece asistencia médica y quirúrgica de primer nivel en todas las especialidades, destacando entre ellas la Obstetricia y Ginecología, la Traumatología y la Pediatría. El centro cuenta con un sólido equipo de profesionales médicos e incorpora los últimos avances funcionales y tecnológicos propios de los centros de medicina más punteros."

During the past decade, Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica" are "Non-small Cell Lung Cancer" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica" are "Drug" (10 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Cisplatin" (4 trials), "Atezolizumab" (3 trials), "Pemetrexed" (3 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".